Hetero Healthcare Expands Oncology Portfolio with Perzea Launch in Collaboration with Enzene…
Hetero Healthcare and Enzene Biosciences have introduced Perzea to expand affordable access to pertuzumab therapy for HER2+ breast cancer, leveraging EnzeneX™ technology.